Drug Shortage Report for PRIORIX-TETRA
Report ID | 55679 |
Drug Identification Number | 02297884 |
Brand name | PRIORIX-TETRA |
Common or Proper name | Combined measles, mumps, rubella and varicella vaccine, live, attenuated |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | MUMPS VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED |
Strength(s) | 25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 10's |
ATC code | J07BD |
ATC description | VIRAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-07-10 |
Estimated end date | 2018-09-07 |
Actual end date | 2018-08-21 |
Shortage status | Resolved |
Updated date | 2018-08-22 |
Company comments | |
Health Canada comments | |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.